Therapeutic mAbs has developed from reshaping antibody and humanized antibody to fully human antibody in order to lower supersensitivity resulting from mouse antibody.

为了降低鼠源抗体引起的超敏反应,治疗隆抗体已由改型抗体,人源化抗体展到全人抗体。